eSUN
A global leader in bio-materials and 3D printing, specializing in the research, production, and sale of high-quality filaments, resins, and biodegradable polymers like PLA and PCL.
- CEO / Founder
- Yang Yihu (Kevin Yang)
- Team Size
- 501-1000
- Stage
- Public
- Total Funding
- $15.0M
- Latest Round
- Strategic Investment
- Key Investors
- SCGC (深创投), Dongxing Securities
Technology & Products
Key Products
Filaments: PLA+/PLA-HS (PLA-HF high-speed to ~1000mm/s), PLA-Coffee, PLA-Matte, ABS+ (2026 upgrade), PETG-ESD, PETG UV color-change, TPU-95A, CF composites (PETG-CF, PA-CF); Resins: W100 water-washable, DM100 dental, Hard-Tough, dental FDA line; Particles (PLA/PETG/TPU/PA-CF); accessories eBOX/eVacuum/eSpool; iSUN3D medical/orthotics & robot applications
Technological Advantage
Maintains a first-mover advantage as the primary drafting unit for China's national standards for PLA 3D printing consumables; holds the world's first patent for bio-based photopolymer resins.
Differentiation
Value Proposition
Delivers a 'Green' closed-loop ecosystem by vertically integrating the synthesis, modification, application, and recycling of bio-based materials, offering professional-grade performance at a competitive cost.
How They Differentiate
Vertical integration of the 'Green' PLA closed-loop ecosystem (synthesis, modification, and chemical recycling) paired with a massive SKU range that spans consumer FDM, industrial resins, and medical-grade orthotics.
Market & Competition
Target Customers
Consumer-grade 3D printing enthusiasts (makers), educational institutions, industrial manufacturing firms, dental labs, and medical rehabilitation centers.
Industry Verticals
Additive Manufacturing, Healthcare & Medical (Orthotics, Dentistry, Implants), Education & Research, Industrial Design & Prototyping, Agriculture (Biodegradable products), Consumer Electronics & Wearables
Competitors
Polymaker; Hatchbox; Sunlu; Formlabs
Growth & Milestones
Growth Metrics
2025 full-year revenue RMB 712M (+31.05% YoY); net profit RMB 18.88M (-21.91% YoY, sales/marketing investment for share). 3D printing materials RMB 640M (+40.25%), ~89.8% of revenue. Revenue path 2023–2025: 4.19→5.44→7.12亿. R&D RMB 23.4M; ~566 employees (94 R&D, 16.6%). National 'Little Giant'.
Major Milestones
Founded in 2002 focusing on biomaterials, Listed on NEEQ (836514) April 2016, Lead drafter ISO 5425:2023 PLA filament standard, iSUN3D medical footwear system 2020; Vietnam manufacturing 2019, 2025 revenue RMB 712M; 3D printing ~90% of sales, Dec 2025: restarted Beijing Stock Exchange (北交所) IPO tutoring with Shenwan Hongyuan; 2 tutoring phases completed by Jul 2026, 2025–2026: Thailand subsidiary ESUN INNOVATION (THAILAND); plan to fully acquire Vietnam CLOVER, 2026: PLA-Coffee (Yum co-dev) at CISCE; ABS+/PETG-UV product upgrades; humanoid-robot materials push
Notable Customers
World Robot Olympiad (WRO); Bambulab users; Maker community; Clinical Orthopedic Centers
Recent coverage of eSUN
- eSUN launches PLA-HF filament for FDM/FFF printing at up to 1000mm/smanilatimes.net
- Guanghua Weiye completes two BJSE tutoring rounds as 3D printing hits 89.9% of CNY 712M revenuecj.sina.cn
- eSUN supplies PA-CF and other materials for University of Pisa electric formula racing carsohu.com
- eSUN is showcasing advanced 3D printing material solutions at CES 2026, specifically targeting functional applications i...nanjixiong.com
- eSUN Launches W200 Water-Washable Resin, Overcoming Mechanical Brittleness of Solvent-Free Materialsnanjixiong.com